METTL3 and metabolic dysfunction-associated steatotic liver disease: In a NAFLD mouse model and FFA-induced hepatocyte model, METTL3/YTHDF1 conjugation mediated m6A modification and promoted Rubicon mRNA expression, which led to hepatic lipid deposition [123].